• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

PLoS One . Regional performance variation in external validation of four prediction models for severity of COVID-19 at hospital admission: An observ

tetano

Editor, Senior Moderator
PLoS One


. 2021 Aug 25;16(8):e0255748.
doi: 10.1371/journal.pone.0255748. eCollection 2021.
Regional performance variation in external validation of four prediction models for severity of COVID-19 at hospital admission: An observational multi-centre cohort study


Kristin E Wickstrøm[SUP] 1 2 [/SUP], Valeria Vitelli[SUP] 3 [/SUP], Ewan Carr[SUP] 4 [/SUP], Aleksander R Holten[SUP] 2 5 [/SUP], Rebecca Bendayan[SUP] 4 6 [/SUP], Andrew H Reiner[SUP] 7 [/SUP], Daniel Bean[SUP] 4 8 [/SUP], Tom Searle[SUP] 4 6 [/SUP], Anthony Shek[SUP] 9 [/SUP], Zeljko Kraljevic[SUP] 4 [/SUP], James Teo[SUP] 9 10 [/SUP], Richard Dobson[SUP] 4 6 8 11 12 [/SUP], Kristian Tonby[SUP] 2 13 [/SUP], Alvaro Köhn-Luque[SUP] 2 [/SUP], Erik K Amundsen[SUP] 1 14 [/SUP]



Affiliations
Free article

Abstract

Background: Prediction models should be externally validated to assess their performance before implementation. Several prediction models for coronavirus disease-19 (COVID-19) have been published. This observational cohort study aimed to validate published models of severity for hospitalized patients with COVID-19 using clinical and laboratory predictors.
Methods: Prediction models fitting relevant inclusion criteria were chosen for validation. The outcome was either mortality or a composite outcome of mortality and ICU admission (severe disease). 1295 patients admitted with symptoms of COVID-19 at Kings Cross Hospital (KCH) in London, United Kingdom, and 307 patients at Oslo University Hospital (OUH) in Oslo, Norway were included. The performance of the models was assessed in terms of discrimination and calibration.
Results: We identified two models for prediction of mortality (referred to as Xie and Zhang1) and two models for prediction of severe disease (Allenbach and Zhang2). The performance of the models was variable. For prediction of mortality Xie had good discrimination at OUH with an area under the receiver-operating characteristic (AUROC) 0.87 [95% confidence interval (CI) 0.79-0.95] and acceptable discrimination at KCH, AUROC 0.79 [0.76-0.82]. In prediction of severe disease, Allenbach had acceptable discrimination (OUH AUROC 0.81 [0.74-0.88] and KCH AUROC 0.72 [0.68-0.75]). The Zhang models had moderate to poor discrimination. Initial calibration was poor for all models but improved with recalibration.
Conclusions: The performance of the four prediction models was variable. The Xie model had the best discrimination for mortality, while the Allenbach model had acceptable results for prediction of severe disease.
 
Back
Top Bottom